So - PRR is in trading halt pending an announcement regarding news from the FDA.
I don't know much at all about FDA processes.
What news do we expect? Is it essentially around the FDA giving a nod of approval to a particular trial design? Particularly around the number of patients to be trialled? And therefore the cost to PRR of completing such a trial?
If so - what would people on this thread consider to be "good" news? What parameters will you be focused on? What would represent "good" news on these parameters??
I look forward to your thoughts.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $350.4M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $225.8K | 931.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 288990 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 21838 | 3 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |